A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the deadliest cancers.

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on ...

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...

High prostate-specific antigen levels before High-Intensity Focused Ultrasound were linked to higher recurrence and treatment failure in intermediate-risk prostate cancer.

Positve overall survival data could lead to a label expansion for Pfizer's combination to treat metastatic ...

There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for patients with stage 3 or 4 kidney cancer, who face high recurrence risk.

The findings could lead to genetic tests that predict the likelihood of disease recurrence in breast cancer patients and ...

The Decipher Bladder Genomic Subtyping Classifier found that patients with luminal tumors may have less aggressive disease.

When prostate cancer metastasizes ... this may be a sign that cancer is metastasizing somewhere in your body. If your healthcare provider suspects your cancer might be spreading, they will likely ...

“Then you are entitled to have the test.” Myth 6: Prostate cancer treatments will end your sex life “Treatments can have an impact on people’s ability to have erections, but this varie ...

A PSA test determines the level of prostate specific antigen in your blood, where increased levels could indicate prostate issues, according to the NHS. Prostate Cancer UK states that 'normal' PSA ...